FDA Inspection
Kaysersberg Pharmaceuticals SASKaysersberg Pharmaceuticals SAS – FDA Inspection, Jul 7, 2023
Record Details
This FDA Inspection record concerns Kaysersberg Pharmaceuticals SAS, with an inspection on July 7, 2023, issued by the Office of Inspections and Investigations.
- Inspection Date
- July 7, 2023
View Company Profile
ID · 62c64822-d91d-4b24-a2f5-63f126424340
Inspection Facts
- Inspection number
- 1211467
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Kaysersberg Pharmaceuticals SAS
4| Date | Classification | Office | Project area |
|---|---|---|---|
| May 17, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 1, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 19, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 19, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Kaysersberg Pharmaceuticals SAS
- FDA Inspection 1268813 - 2024-05-17
- FDA Inspection 1123773 - 2019-02-01
- FDA Inspection 981303 - 2016-07-19
- FDA Inspection 661210 - 2010-04-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.